… Background Inhaled corticosteroids (ICS) are known to increase the risk of pneumonia in …
It is unclear whether the risk of pneumonia varies for different inhaled agents, particularly …

… pneumonia and the use of inhaled corticosteroids. We aimed to ascertain the risk of pneumonia
with long-term inhaled corticosteroid use … trials of any inhaled corticosteroid vs a control …

… The use of inhaled corticosteroids has been associated with an increased … study do not
support any increased risk of pneumonia in patients with asthma using inhaled corticosteroids. …

… , we found that current inhaled corticosteroid use was associated with a significant 70%
increase in the risk of being hospitalized for pneumonia. This risk increased with higher doses of …

… the magnitude of this risk, the … of inhaled corticosteroids in individuals with COPD—is difficult.
Understanding of the mechanisms of increased pneumonia risk with inhaled corticosteroids …

… Safety concerns related to inhaled steroids highlighted in this … with increased risk of serious
adverse pneumonia events, but … in serious pneumonias, mortality or serious adverse events, …

… The use of inhaled corticosteroids (ICS) in COPD may be associated with an increased risk
of pneumonia. Little is known of this risk in newly diagnosed COPD patients. The objective of …

… this cohort, we identified patients with pneumonia or lower respiratory tract infection and age-
… type of inhaled corticosteroid and the risk of pneumonia or lower respiratory tract infection. …

… Risk factors for pneumonia Irrespective of randomised treatment, the risk factors for pneumonia
in this study population are summarised in figure 2⇓. This shows the hazard ratios and …

… BUD also increased the risk of nonfatal serious pneumonia … % higher risk of less serious,
community-managed pneumonia events … with respect to serious pneumonia events or mortality. …